aDepartment of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China bDepartment of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang ...

vThe Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China wDepartment of Women and Children’s Health, School of Life ...

The paper presents a novel method for RSA, called trial-level RSA (tRSA). The method first constructs a trial x trial representation dissimilarity matrix using correlation distances, assuming that (as ...

eClinical Solutions LLC, a global provider of digital clinical software and services, today announced its participation in several June events, including the DIA 2025 Global Annual Meeting ...

From disease understanding and drug interactions to clinical ... here. Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow ...

MK-1084, Merck’s investigational KRAS G12C inhibitor, showed a manageable safety profile along with antitumor activity in the Phase I KANDLELIT-001 study. Early-phase trial design should anticipate ...

today integrated Trial Insights™—its real‑time clinical‑trial analytics tool—into Clinical Labs Navigator™. The move lets scientists source lab services and query more than 500,000 ...

For instance, FDA’s Good Review Practice - Clinical Review of Investigational New Drug Applications document includes randomization as one of the “critical aspects of overall development and trial ...

A first-of-its-kind clinical trial shows that therapeutic plasma exchange ... More information: Matias Fuentealba et al, Multi‐Omics Analysis Reveals Biomarkers That Contribute to Biological ...

When you think of clinical trials for cancer, testing a new medication may come to mind. But drugs aren’t the only thing these trials investigate. There’s a growing world of nonpharmaceutical ...